Anemia in heart failure.
Chronic heart failure is a common problem and a major cause of death, hospital admission, poor physical function and impaired quality of life. In addition to the direct effect of heart failure on prognosis, several modifiable and non-modifiable factors contribute to the worse prognosis in heart failure. Anemia, which is common in patients with heart failure, may represent a modifiable risk factor for adverse outcome. It is also a marker for co-morbidity burden and greater disease severity.  If anemia is a marker, treatment may not obviate the increased risk associated with anemia, but if it is a mediator, treatment may be helpful to reduce morbidity and mortality in heart failure. As anemia has been identified as an independent prognostic factor of both morbidity and mortality for patients with congestive heart failure, there is an increased interest in the hypothesis that the correction of anemia with erythropoietin or iron supplementation might lead to an improvement on patients' symptoms and functional status. Large randomized trials are necessary to show the effect of anemia and the specific treatments on the outcome in these patients. This article reviews the mechanisms, impact on outcomes and therapy of anemia in patients with heart failure.
Clinic of Cardiology, Kocaeli State Hospital, Kocaeli-Turkey. akilicgedik@yahoo.com
Alev
A
Kılıçgedik
Cihan
C
Dündar
Mustafa Kürşat
MK
Tigen
D000740:Anemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006333:Heart Failure / Q000097:blood / Q000150:complications*; D006801:Humans